Metis TechBio CEO Discusses Success of HKEX Debut and Potential Risks
Metis TechBio debuts on HKEX Main Board, raises $270m. CEO Chris Lai discusses the AI-designed drug delivery system and its risks.
Browsing Tag
Biotech and Pharmaceuticals
U.S. selects HIV, arthritis drugs for upcoming Medicare price negotiations
The U.S. government announces 15 new drugs for Medicare price negotiations in 2028, including treatments by Gilead…
Eli Lilly Reaches $1 Trillion Market Cap, First Healthcare Firm to Do So
Eli Lilly becomes the first healthcare company to reach a $1 trillion market cap, riding high on the success of its…
Novo Nordisk’s GLP-1 Pill Makes Key Progress
Novo Nordisk's pill, oral semaglutide, has scored approval for slashing cardiovascular risks, further confirming its health benefits beyond diabetes treatment.
Trump’s Health Care Bill Risks Coverage for Millions, Threatens Rural…
Trump's "big, beautiful bill" plans sweeping changes to U.S. healthcare, potentially leaving millions uninsured and…